GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
148 hedge funds and large institutions have $1,000M invested in GenMark Diagnostics, Inc in 2020 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 52 increasing their positions, 30 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
+38
Holders Change %
+34.55%
% of All Funds
3.04%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
%
% of All Funds
0.06%
New
56
Increased
52
Reduced
30
Closed
17
Calls
$3.33M
Puts
$1.76M
Net Calls
+$1.58M
Net Calls Change
+$1.81M
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$101M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$72.1M |
| 3 |
Renaissance Technologies
New York
|
+$30.8M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$19.6M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$19.4M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$66.9M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$26M |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$19.4M |
| 4 |
CCM
Cadian Capital Management
New York
|
-$14.4M |
| 5 |
CC
Casdin Capital
New York
|
-$13.9M |
